Scarica l'app Stockscreener
1.06
4.95%
0.05
Dopo l'orario di chiusura:
1.07
0.01
+0.94%
Precedente Chiudi:
$1.01
Aprire:
$1.02
Volume 24 ore:
881.27K
Relative Volume:
0.34
Capitalizzazione di mercato:
$71.81M
Reddito:
-
Utile/perdita netta:
$-46.12M
Rapporto P/E:
-1.2266
EPS:
-0.8642
Flusso di cassa netto:
$-41.02M
1 W Prestazione:
+3.92%
1M Prestazione:
-16.54%
6M Prestazione:
+32.83%
1 anno Prestazione:
-50.93%
Intervallo 1D:
$1.01
$1.08
Intervallo di 1 settimana:
$0.9607
$1.12
Portata 52W:
$0.7113
$2.77
Inflarx N V Stock (IFRX) Company Profile
Confronta IFRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
1.06 | 68.42M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-03 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-09-02 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-29 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-02-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-10-28 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | Iniziato | H.C. Wainwright | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-04-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-05 | Downgrade | JP Morgan | Overweight → Underweight |
| 2019-06-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | Downgrade | SunTrust | Buy → Hold |
| 2019-01-29 | Iniziato | Robert W. Baird | Outperform |
| 2018-12-10 | Iniziato | Credit Suisse | Outperform |
| 2018-07-13 | Iniziato | BMO Capital Markets | Outperform |
| 2018-06-28 | Iniziato | Raymond James | Outperform |
| 2018-06-28 | Iniziato | SunTrust | Buy |
| 2018-02-08 | Iniziato | B. Riley FBR, Inc. | Buy |
Mostra tutto
Inflarx N V Borsa (IFRX) Ultime notizie
InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
InflaRx Stock Rises 8% on Conditional EC Nod for COVID-19 Drug - MSN
InflaRx NV Stock Analysis and ForecastStock Split Announcements & Big Gains Low Investment - earlytimes.in
Can Northern Spirits Limited Outperform Index Funds Over the Next 5 YearsAnalyst Downgrades & Small Investment Big Gains - earlytimes.in
InflaRx’s oral C5aR inhibitor receives WHO generic name izicopan By Investing.com - Investing.com South Africa
InflaRx’s oral C5aR inhibitor receives WHO generic name izicopan - Investing.com India
InflaRx N.V. Announces WHO Grant of International Nonproprietary Name “izicopan” for C5aR Inhibitor INF904 - Quiver Quantitative
InflaRx Announces International Nonproprietary Name of “Izicopan” for INF904 - Yahoo Finance
Gap Down: Why InflaRx NV stock is a value investor pickMarket Trend Review & Safe Entry Zone Tips - moha.gov.vn
Investors in cash trouble should check out InflaRx N.V (IFRX) - setenews.com
Risk Off: What margin trends mean for InflaRx NV stockTrade Performance Summary & Free Real-Time Volume Trigger Notifications - BỘ NỘI VỤ
Risks Report: Will InflaRx NV stock outperform Nasdaq index2025 Macro Impact & Real-Time Chart Breakout Alerts - moha.gov.vn
InflaRx (NASDAQ:IFRX) Downgraded to "Hold" Rating by Leerink Partnrs - MarketBeat
How InflaRx N.V. (IF0) stock moves in volatile trading sessions2025 Technical Overview & Reliable Volume Spike Alerts - Newser
InflaRx (NASDAQ:IFRX) Stock Rating Lowered by Leerink Partnrs - Defense World
Will InflaRx N.V. stock outperform Nasdaq indexJuly 2025 Update & Community Supported Trade Ideas - Newser
Is InflaRx N.V. (IF0) stock testing key supportWeekly Market Report & Risk Controlled Swing Alerts - Newser
Leerink Partners downgrades Inflarx stock rating to Market Perform on financing concerns - Investing.com Australia
InflaRx (IFRX) Downgraded by Leerink Partners with Lowered Price Target | IFRX Stock News - GuruFocus
Leerink Partners Downgrades InflaRx to Market Perform From Outperform, Adjusts PT to $2 From $5 - marketscreener.com
InflaRx Announces Positive Phase 2a Results for INF904 in HS and CSU - MSN
InflaRx N.V. (IFRX) 5.6% in After-hours: What’s Driving the Move? - Stocks Telegraph
Will InflaRx N.V. (IF0) stock deliver compounding returns2025 Investor Takeaways & Capital Efficiency Focused Strategies - Newser
Is InflaRx N.V. (IF0) stock supported by strong fundamentalsStop Loss & Verified Short-Term Trading Plans - Newser
What margin trends mean for InflaRx N.V. stock2025 Market Outlook & AI Forecasted Entry/Exit Points - Newser
Inflarx flexes; HS, CSU continue to percolate - BioWorld MedTech
Ready to Jump After Recent Trade: InflaRx N.V (IFRX) - setenews.com
Cash per share of InflaRx N.V. – BER:IF0 - TradingView
InflaRx N.V. (NASDAQ:IFRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Can InflaRx N.V. (IF0) stock surprise with quarterly results2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
Will InflaRx N.V. stock deliver strong dividend growthGold Moves & AI Enhanced Trading Signals - newser.com
Is InflaRx N.V. stock attractive for income investorsEarnings Risk Report & Stepwise Trade Execution Plans - newser.com
Can InflaRx N.V. stock sustain market leadershipWeekly Trend Recap & AI Driven Price Predictions - newser.com
InflaRx N.V. stock prediction for this weekMarket Rally & AI Driven Price Predictions - newser.com
Is InflaRx N.V. (IF0) stock cheap vs fundamentalsJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
InflaRx Stock: Gohibic Flops, INF904 Underwhelms, Cash Burn Accelerates (NASDAQ:IFRX) - Seeking Alpha
Can InflaRx N.V. recover in the next quarter2025 Stock Rankings & Technical Pattern Based Signals - newser.com
Will InflaRx N.V. (IF0) stock maintain strong growthMarket Growth Review & Low Risk High Reward Ideas - newser.com
Why InflaRx N.V. stock is considered a top pickMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Inflarx N V Azioni (IFRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):